Bandingkan Harga & Kinerja Geoprima Solusi Tbk. (GPSO) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Geoprima Solusi Tbk. dan Organon Pharma Indonesia Tbk.: Geoprima Solusi Tbk. diperdagangkan di Rp288 (kapitalisasi pasar 208,29 M, volume 24 jam 47,55 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Geoprima Solusi Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| GPSO | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 208,29 M | 104,4 M |
Volume | 47,55 jt | — |
Lot | 475,51 rb | — |
Perputaran | 13,55 M | — |
Harga Rata-rata | 285,01 | — |
Nilai Transaksi | 13,55 M | — |
Harga Ekuilibrium Indikatif | 288 | — |
Volume Ekuilibrium Indikatif | 39,66 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Geoprima Solusi Tbk.
PT Geoprima Solusi Tbk (the “Company”) was established in the Republic of Indonesia on March 6, 1997, under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Notarial Deed No. 15 dated March 6, 1997 of Jimmy Simanungkalit, S.H., Notary in Jakarta. The Company started its commercial operation in 1998.
Selengkapnya di halaman GPSO →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
